预先存在的全身炎症会损害脏中的细菌清除
Katja Hanslin1, Paul Skorup2, Frida Wilske2
1Department of Surgical Sciences/Anesthesiology and Intensive Care Medicine, Uppsala University, Uppsala, Sweden. katja.hanslin@uu.se.
Intensive care medicine experimental
|February 4, 2026
概括
先前存在的全身炎症会影响脏细菌清除,尽管内毒素消除没有变化. 在这种情况下,对细菌病的炎症反应减少,这表明脏特异性机制参与其中.
科学领域:
- 免疫学 免疫学 免疫学
- 败血症研究 败血症研究
- 微生物学 微生物学
背景情况:
- 败血症诱导的免疫抑制会影响细菌清除,并提高死亡率.
- 肝脏和脏巨细胞是单核细胞系统的关键组成部分,用于细菌的消除.
- 系统性炎症对肝脏中的细菌清除产生负面影响,促使对脏功能进行调查.
研究的目的:
- 为了研究一种假设,即系统性炎症诱导的免疫抑制降低了脏的细菌清除.
- 评估先前存在的系统性炎症对脏细菌清除和内毒素消除的影响.
- 评估正在进行的炎症背景下对细菌病的炎症和生理反应.
主要方法:
- 麻醉后的猪在重症监护室接受了大肠杆菌输液.
- 组包括天真 (只有大肠杆菌),ETX (内毒素预暴露,随后是大肠杆菌) 和控制 (盐水).
- 分析了细菌数量,内毒素水平,IL-6,TNF和生理反应.
主要成果:
- 在动脉,脏静脉或肝静脉细菌计数方面没有发现显著差异.
- 脊髓静脉与动脉细菌计数的比率在天真组相比ETX组较低.
- 天真组的IL-6和TNF峰值水平较高;在ETX组中对大肠杆菌的生理反应减弱.
结论:
- 预先存在的全身炎症会影响脏细菌清除,但不会影响内毒素的排出.
- 在持续的炎症期间,对细菌病的炎症和生理反应会减少.
- 结果表明固有的脏机制参与其中,因为ex vivo杀菌能力不受影响.
相关概念视频
01:17Factors Affecting Renal Clearance: Renal Impairment
480
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
480
01:38Inflammation
62.2K
Overview
62.2K
01:17Gram-negative Bacterial Protein Secretion Systems
952
Gram-negative bacteria utilize sophisticated protein secretion systems to transport proteins across their double-membrane envelope into the extracellular environment or host cells. Based on their mechanism of action, these systems are classified into one-step and two-step pathways.One-Step Secretion Systems (Types I, III, IV, and VI)One-step secretion systems bypass the periplasm entirely, forming a continuous channel that spans both the inner and outer membranes:Type I Secretion System (T1SS):...
952
01:09Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
523
Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
Most drugs undergo restrictive clearance, which is proportional to the...
523
01:23Renal Clearance
2.7K
The glomerular filtration rate (GFR) is a critical marker of kidney function, reflecting the efficiency of filtration by the glomeruli. Renal clearance of specific substances, such as inulin or creatinine, is commonly used to measure GFR.
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
2.7K
02:01pre-mRNA Processing
57.6K
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
57.6K